32 results
424B3
OCUP
Ocuphire Pharma Inc
16 Feb 24
Prospectus supplement
4:31pm
in the banking system and financial markets, lingering COVID-19 pandemic, increased inflation and increased interest rates. The general economic and capital … and financial markets, and steps taken by governments and central banks, particularly in response to the COVID-19 pandemic as well as other stimulus
424B5
OCUP
Ocuphire Pharma Inc
14 Aug 23
Prospectus supplement for primary offering
8:00am
as a result of supply chain disruptions and the ongoing COVID-19 pandemic. These factors include those described in this “Risk Factors” section … , including due to the COVID-19 pandemic.
In addition, the stock markets in general, and the markets for biopharmaceutical stocks in particular, have
8-K
EX-10.1
np8gzi7icfn
7 Nov 22
Ocuphire to Receive $35 Million Upfront, Nyxol Development Funding and Additional Potential Milestone Payments plus Tiered Double-Digit Royalties
4:16pm
8-K
EX-10.1
wzj5f z6c86wvix790
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
424B5
w7smxh n6
7 Jun 21
Prospectus supplement for primary offering
4:21pm
424B5
hg40b5b xiz05j477wj3
11 Mar 21
Prospectus supplement for primary offering
9:19am
8-K
EX-99.1
jiylm7j
11 Mar 21
Ocuphire Announces Financial Results for the Full Year 2020 and Provides Corporate Update
9:12am